The National Times - Cooling US jobs market in focus as political scrutiny heats up

Cooling US jobs market in focus as political scrutiny heats up


Cooling US jobs market in focus as political scrutiny heats up
Cooling US jobs market in focus as political scrutiny heats up / Photo: © AFP/File

US employment data on Friday is expected to confirm a cooled labor market, as companies pull back on hiring amid continued uncertainty over President Donald Trump's tariffs.

Change text size:

But the jobs report is set to attract heightened scrutiny, after a poor showing last month prompted Trump to claim the numbers were "rigged" and take the unprecedented action of firing the commissioner of labor statistics.

US job growth missed expectations in July, while revisions to hiring figures in recent months brought them to the weakest levels since the Covid-19 pandemic.

Hours after the data release, Trump charged that Commissioner Erika McEntarfer had "faked" jobs data to boost Democrats' chances of victory in the recent presidential election.

He also pointed to the downward revisions to hiring numbers, saying that similar things have happened this year -- amid his return to the presidency in January -- and "always to the negative."

But Nationwide chief economist Kathy Bostjancic told AFP that data revisions take place as survey response rates have declined.

If companies respond late, numbers have to be updated to reflect incoming data.

"I've never viewed the data as being politically determined or influenced," she said. But she conceded that "there's room for improvement in data collection."

- 'Fragile balance' -

For now, EY chief economist Gregory Daco anticipates Friday's report "to confirm that a marked slowdown in labor market conditions is underway."

This comes as business leaders "continue to restrain hiring" as they grapple with softer demand, higher costs and interest rates, he wrote in a note.

Trump's stop-start approach to rolling out tariffs has snarled supply chains and made it tough for businesses to plan their next moves. Many firms said they have been forced to put growth plans on hold.

A Briefing.com consensus forecast expects US hiring to pick up slightly to 78,000 in August from 73,000 in July.

The unemployment rate, meanwhile, is anticipated to edge up from 4.2 percent to 4.3 percent.

While this appears to be an improvement, KPMG senior economist Kenneth Kim told AFP that "last year, the average payroll gain per month was 168,000."

The average so far this year, he said, was 85,000 -- about half the pace seen in 2024.

"Recent data highlights a fragile balance in the labor market: labor demand and supply have become subdued, while layoffs remain limited," Daco said.

"Increasingly, job creation is concentrated within a couple of private-sector industries," he added.

He also warned that the labor force participation rate will likely edge down as stricter immigration policies under the Trump administration increasingly constrain worker flows in the coming months.

- Rate cut incoming -

If Friday's data came in as expected, "there's a very high probability" that the Federal Reserve will lower interest rates at the end of its policy meeting from September 16-17, said Kim of KPMG.

Since its last cut in December, the US central bank has held interest rates steady at a range between 4.25 percent and 4.50 percent.

In doing so, Fed policymakers have been balancing between risks of inflation and a deteriorating jobs market.

Economists have warned that Trump's wide-ranging tariffs on imports could fuel inflation and bog down economic growth over the long run.

The Fed is monitoring the duties' effects on consumer prices as officials mull the right timing for their next rate cut, despite Trump's growing calls for swift and significant reductions.

A jobs report signaling a tepid labor market would likely support the need for a cut to boost the economy, while a surprisingly strong showing might instead tip the odds in the other direction.

P.Johnston--TNT

Featured

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

CapTLX, the securities trading and investment platform operated by CHAINLION TECH LTD, today announced the continued expansion of its technology infrastructure for qualified investors and institutional market participants seeking structured access to U.S. equity and private capital markets.

Change text size: